Zilong Zhang

Zilong Zhang

Auto-generated profile, based on publicly available information

Zilong Zhang

School of Computer Science and Technology, Hainan University, Haikou, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
YMYajie Meng
Yajie Meng
ZZZhuang Zhang
Zhuang Zhang
XSXudong Shang
Xudong Shang
XTXianfang Tang
Xianfang Tang
JLJincan Li
Jincan Li
PWPeng Wang
Peng Wang
Leveraging the wealth of biomedical data available, we can derive insights into the relationships between biological entities from various angles. This underscores the complexity and significance of developing a dynamic approach for integrating data from multiple sources, a critical endeavor in drug recommendation. In this study, we introduce an innovative deep learning approach termed “Multi-View Fusion Strategy with Self-Attention” (FusionMVSA), designed to predict associations between drugs and diseases. To effectively amalgamate data from diverse sources and extract representative features, we have developed a feature extraction mechanism that capitalizes on similarities. This mechanism computes self-attention across multiple perspectives using shared group parameters, thereby highlighting common characteristics. Simultaneously, we utilize biomedical similarities among multi-source data as guiding factors for calculating similarity, enabling the capture of more nuanced features. Subsequently, we integrate these features through a feature fusion process, where known associations between drugs and diseases act as guiding terms. This strategy allows us to uncover the complementary aspects of different viewpoints. Ultimately, we predict potential drug-disease associations using a multi-layer perceptron neural network. Our methodology has undergone rigorous testing through various cross-validation experiments and case studies. We are confident that FusionMVSA will prove to be a valuable tool in drug recommendation, offering new avenues for exploration and discovery in the quest to combat diseases.

4 March 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
SGShun Gao
Shun Gao
YXYan Xia
Yan Xia
XLXingfeng Li
Xingfeng Li
Feifei CuiFeifei Cui
Feifei Cui
FBFanyu Bu
Fanyu Bu
ZZZilong Zhang
Zilong Zhang
Anticancer peptide (ACP) are short peptides with anti-cancer properties that have generated increasing attention in recent years due to their low toxicity, minimal side effects, and their ability to precisely target and kill cancer cells. Traditionally, identifying ACP has relied on experimental methods, which are time-consuming and labor-intensive. While deep learning-based prediction methods have made significant progress, there is still room for improvement in achieving optimal performance. In this study, we present ACP-ESM2, a deep learning framework based on the Evolutionary Scale Modeling 2 (ESM2) pre-trained model, which captures rich evolutionary information from protein sequences. By combining ESM2 with convolutional neural network (CNN) that excels at detecting local patterns, ACP-ESM2 offers a highly accurate tool for ACP prediction. The experimental results indicate that ACP-ESM2 shows significant improvements over best-existing recognition techniques on the Test1 set, with enhancements of 2.3%, 7.2%, 12.6%, and 5% in ACC, SN, SP, and MCC, respectively. Notably, on the Test2 set, ACP-ESM2 achieves an accuracy of 97.6%, showcasing its exceptional robustness. This establishes ACP-ESM2 as an efficient and precise tool for predicting anticancer peptides. To facilitate predictions for researchers, we have set up a web server for ACP-ESM2, which is available at http://www.bioailab.com/ACP-ESM2.

22 May 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
CYChao Yang
Chao Yang
XFXiuhao Fu
Xiuhao Fu
ZLZhenjie Luo
Zhenjie Luo
LWLeyi Wei
Leyi Wei
JLJingbing Li
Jingbing Li
ZZZilong Zhang
Zilong Zhang
Spatial transcriptomics analysis methods offer an opportunity to investigate highly diverse biological tissues. Cell-cell communication is fundamental for maintaining physiological homeostasis in organisms and coordinating complex biological processes. Identifying cell-cell interactions is critical for understanding cellular activities. The interaction of a cell with other cells depends on several factors, and most of the existing methods that consider only gene expression information of neighbouring cells and spatial location information are somewhat limited. In this paper, we propose a network architecture based on graph convolution network and long short-term memory attention module-GCNLA, which contains graph convolution layer, long short-term memory network, attention module, and residual connections. GCNLA not only learns the spatial structure of cells but also captures interaction information between distal cells, the attention module further extracting and enhancing features related to cell-cell interactions. Finally, the inner product decoding calculates the cosine similarity, which is used to infer cell-cell interactions. In addition, GCNLA is capable of reconstructing the complete cell-cell interaction network. The experimental results on seqFISH and MERFISH demonstrate that the GCNLA network structure has better robustness and noise immunity. The potential features learned by GCNLA enable other downstream analyses, including single-cell resolution cell clustering based on spatial information resolving cell heterogeneity.

11 December 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
SXShuwen Xiong
Shuwen Xiong
Feifei CuiFeifei Cui
Feifei Cui
ZZZilong Zhang
Zilong Zhang
RZRao Zeng
Rao Zeng
RSRan Su
Ran Su
LWLeyi Wei
Leyi Wei
Cyclic peptides represent a rapidly growing class of therapeutics, yet their development is often hindered by the challenge of predicting cell membrane permeability, a critical determinant of drug efficacy. Existing computational methods often struggle to integrate the diverse structural information inherent in these complex molecules, resulting in suboptimal predictive accuracy. Here, we introduce MCPerm, a multi-modal deep learning framework that synergistically integrates 1D SMILES, 2D topological, and 3D geometric information through a novel modality share and contrastive learning strategy to accurately predict cyclic peptide permeability. MCPerm fine-tunes a pretrained peptide language model for SMILES encoding and uses a parameter-sharing graph transformer for structural representation, while a dual contrastive learning mechanism enforces representational consistency both within and between modalities. On the benchmark PAMPA dataset, MCPerm achieves state-of-the-art performance, significantly outperforming leading methods. We further demonstrate its robustness and competitive transferability across three independent assays (Caco-2, MDCK, and RRCK). Our work presents a robust in silico framework that holds potential to accelerate the rational design and discovery of cell-permeable cyclic peptide drugs. Furthermore, to move beyond predictive accuracy, we introduced an attention-based visualization analysis. The results demonstrate that our model is not a “black box”; it has learned key chemical principles governing cyclic peptide permeability.

23 December 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
JYJiahao Yuan
Jiahao Yuan
SGShun Gao
Shun Gao
ZYZiyuan Yan
Ziyuan Yan
Feifei CuiFeifei Cui
Feifei Cui
LWLeyi Wei
Leyi Wei
ZZZilong Zhang
Zilong Zhang
2'-O-methylation (2OM) of ribose is a widespread RNA modification that significantly impacts RNA stability, structure, and function. Accurately predicting 2OM sites is crucial for understanding RNA's biological functions and related pathologies. Traditional detection methods pose challenges such as resource intensiveness, potential RNA sample damage, and high costs. However, recent advancements in machine learning, particularly deep learning techniques, offer rapid and cost-effective prediction solutions. In this study, we introduce DeepR2OM, a novel method integrating feature selection and deep learning for 2OM sites prediction. DeepR2OM encodes sequences using eight RNA descriptors, employs feature selection algorithms to reduce dimensions, and then utilizes a deep learning network for training. After evaluating various deep learning architectures, we selected Convolutional Neural Network (CNN), Multi-Head Self-Attention mechanism, and Deep Neural Network (DNN) as our final prediction models. Experimental results demonstrate DeepR2OM's effectiveness, achieving 87.1% accuracy (ACC), 85.5% recall rate (Recall), 87.9% precision (PRE), and a Matthews correlation coefficient (MCC) of 75.7% on an independent test set. This tool serves as a valuable resource for exploring the functional and bioinformatic aspects of 2OM sites. To enhance accessibility, we have developed a web server for the prediction of RNA 2'-O-Methylation

3 December 2025 in IEEE Transactions on Computational Biology and Bioinformatics
Verified
Journal Article
Closed access
BZBuchao Zhan
Buchao Zhan
DHDongmei He
Dongmei He
XYXin Yang
Xin Yang
ZZZilong Zhang
Zilong Zhang
SYShankai Yan
Shankai Yan
Objective: The role of fungal microbiota in human carcinogenesis remains largely uncharacterized. Recent evidence suggests normal adjacent tissue (NAT) represents an intermediate state between healthy and malignant tissues, highlighting its potential for early cancer detection. Discriminating fungal compositional profiles between tumor and NAT is thus critical for elucidating fungal involvement in oncogenesis. However, the high similarity between tumor and NAT mycobiota poses significant analytical challenges. Method: To overcome this limitation, we developed a two-level ensemble discriminative model. Base-level classifiers, trained using rigorously filtered fungal microbiota data (based on prevalence, abundance, and quality metrics) via Random Forest, generate initial predictions. A meta-level classifier then integrates these base predictions, transforming high-dimensional, sparse fungal feature data into a low-dimensional, dense representation optimized for discrimination. Model implementation and analysis code are available at: https://github.com/cskyan/FNatPred. Results: Our approach achieved clear separation between tumor and NAT mycobiomes across multiple cancer types, with particularly pronounced discrimination in colorectal cancer (CRC). The proposed model significantly outperformed existing methods in tumor-NAT classification, demonstrating an average AUC improvement of approximately 10%.